This inventor holds 1 USPTO granted patent. Top assignee: Vita Genomics, Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations of Shih Hsin Wu in Asthma Diagnosis
Introduction
Shih Hsin Wu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of genetics, particularly in relation to asthma susceptibility. His work focuses on the Protein-Tyrosine Phosphatase Receptor-type Delta (PTPRD) gene, which plays a crucial role in understanding asthma and related infections.
Latest Patents
Shih Hsin Wu holds a patent titled "Single nucleotide polymorphisms in protein-tyrosine phosphatase receptor-type delta for the diagnosis of susceptibility to asthma." This patent outlines a method for detecting the asthma-associated gene, predicting the occurrence of asthma, and identifying asthma-associated alleles in the PTPRD gene. Additionally, it includes methods for screening PTPRD for drugs useful in asthma treatment and antibodies specific for PTPRD variants for use in diagnostic assays. He has 1 patent to his name.
Career Highlights
Wu is currently associated with Vita Genomics, Inc., where he continues to advance research in genetic diagnostics. His innovative approach has the potential to improve asthma diagnosis and treatment options significantly.
Collaborations
One of his notable coworkers is Ellson Ye-Shyon Chen, who contributes to the collaborative efforts in their research endeavors.
Conclusion
Shih Hsin Wu's work in the field of genetics, particularly regarding asthma susceptibility, showcases the importance of innovation in medical diagnostics. His contributions are paving the way for better understanding and treatment of asthma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile